New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR

ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders

New Retina Radio Journal Club w/ VBS: Obstructive Sleep Apnea and Diabetic Retinopathy

The State of Geographic Atrophy Around the Globe: Part 2 of 2

The State of Geographic Atrophy Around the Globe: Part 1 of 2

Diabetic Retinopathy Severity and Income Status

GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing Therapy

GA in 2025: Dosing Regimens, Drug Selection, and Ideal Candidates

Photobiomodulation for Age-related Macular Degeneration

Duke AVS Clips: PVR, DR, Imaging, and MTM

Duke AVS Clips: Pediatrics, Anesthesia Trends, and AI

Duke AVS Clips: Gene Therapy, RDs, IOLs, and PVDs

ARVO '25: ISTH0036 in Wet AMD/DME, and New Photobiomodulation Data

ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the Pipeline

GLP-1s and Risk of Age-Related Ocular Disease

Fellow Eye RRD Risk per IRIS Registry

Rates of Ocular AEs After Faricimab Injection

Treating Geographic Atrophy (GA) In Your Practice

Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy